PHK
RIGL icon

Point72 Hong Kong’s Rigel Pharmaceuticals RIGL Stock Holding History

Point72 Hong Kong’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-4,221
Closed -$50K – 1351
2022
Q3 		$50K Buy
+4,221
New +$57.1K ﹤0.01% 1423
2022
Q2 		– Sell
-452
Closed -$14K – 2333
2022
Q1 		$14K Sell
452
-235
-34% -$6.36K ﹤0.01% 1565
2021
Q4 		$18K Sell
687
-117
-15% -$3.53K ﹤0.01% 1561
2021
Q3 		$29K Buy
+804
New +$31.6K ﹤0.01% 1629
2021
Q2 		– Sell
-136
Closed -$5K – 2283
2021
Q1 		$5K Sell
136
-214
-61% -$8.47K ﹤0.01% 1654
2020
Q4 		$12K Buy
350
+72
+26% +$2.08K ﹤0.01% 1510
2020
Q3 		$7K Buy
+278
New +$6.83K ﹤0.01% 1035
2019
Q4 		– Sell
-212
Closed -$4K – 1413
2019
Q3 		$4K Buy
+212
New +$4.38K ﹤0.01% 831
2018
Q3 		– Sell
-30
Closed -$1K – 1133
2018
Q2 		$1K Buy
+30
New +$1.07K ﹤0.01% 836
2016
Q4 		– Sell
-720
Closed -$26K – 1013
2016
Q3 		$26K Buy
+720
New +$20.6K 0.01% 554

Other funds holding RIGL

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Point72 Hong Kong's RIGL Position: Q4 2022 in Review

Point72 Hong Kong sold out of Rigel Pharmaceuticals (RIGL) in Q4 2022, closing a stake of 4,221 shares — an estimated $50K sold.

Point72 Hong Kong first reported a position in RIGL in Q3 2016 and held it in 10 quarters. The position peaked at $50K in Q3 2022. 118 funds tracked by Wall St. Rank hold RIGL as of Q4 2022.

  • Point72 Hong Kong reported no remaining Rigel Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 4,221 Rigel Pharmaceuticals shares in Q4 2022, an estimated $50K.
  • Point72 Hong Kong first reported a position in Rigel Pharmaceuticals in Q3 2016 and held it in 10 quarters.
  • Point72 Hong Kong's Rigel Pharmaceuticals position peaked at $50K in Q3 2022.
  • 118 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q4 2022.

Based on Point72 Hong Kong's 13F filing for Q4 2022, filed 14 Feb 2023.